Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a ‘melphalan recall’ reaction

Por Rosenzweig, M, Seldin, DC, Remick, DG, Skinner, M, Quillen, K, Oran, B, Finn, KT, Sanchorawala, V
Publicado em 2009

High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution

Por Seldin, D. C., Andrea, N., Berenbaum, I., Berk, J. L., Connors, L., Dember, L. M., Doros, G., Fennessey, S., Finn, K., Girnius, S., Lerner, A., Libbey, C., Meier-Ewert, H. K., O’Connell, R., O’Hara, C., Quillen, K., Ruberg, F. L., Sam, F., Segal, A., Shelton, A., Skinner, M., Sloan, J. M., Wiesman, J. F., Sanchorawala, V.
Publicado no Amyloid (2011)